Atreya, I; Neurath, MF
Understanding the delayed onset of action of azathioprine in IBD: are we there yet?Gut. Bd. 58. H. 3. 2009 S. 325-6
Zenker, S; Atreya, I; Becker, C et al.
Vav1 Acts As An Essential Modulator in Colitis Associated Colon CancerGASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A466-A466
Correa, F; Docagne, D; Mestre, L et al.
Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite, prostamide E 2.Biochem J. Bd. 409. H. 03. 2008 S. 761-70
Pali-Schöll, I; Yildirim, AO; Ackermann, U et al.
Anti-acids lead to immunological and morphological changes in the intestine of BALB/c mice similar to human food allergy.Exp Toxicol Pathol. Bd. 60. H. 4-5. 2008 S. 337-45
Atreya, I; Neurath, MF
Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implicationsExpert Rev Gastroenterol. Hepatol. Bd. 2. H. 1. 2008 S. 23-34
Waisman, A; Yogev, N
B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral toleranceEur J Immunol. Bd. 39. H. 6. 2008 S. 1448-51
Siebler, J; Wirtz, S; Frenzel, C et al.
Cutting edge: a key pathogenic role of IL-27 in T cell- mediated hepatitis.J Immunol. Bd. 1. H. 180. 2008 S. 30-33
Frank, H; Gröger, N; Diener, M et al.
Lactaturia and loss of sodium dependent lactate uptake in the colon of SLC5A8 deficient miceJ Biol Chem. Bd. 283. H. 36. 2008 S. 24729-25737
Huber, S; Schrader, J; Fritz, G et al.
P38 MAP kinase signaling is required for the conversion of CD4+CD25 iTreg.PLoS One. Bd. 3. H. 10. 2008 S. e3302
Weigmann, B; Lehr, HA; Yancopoulos, G et al.
The transcription factor NFATc2 controls IL-6 – dependent T cell activation in experimental colitisJ Exp Med. Bd. 205. H. 8. 2008 S. 2-12